Favicon of Pear Therapeutics (reSET)

Pear Therapeutics (reSET)

reSET is a prescription digital therapeutic that delivers a 12-week course of cognitive behavioral therapy with contingency management through a smartphone app, as an adjunct to outpatient treatment for substance use disorder in adults. It was developed by Pear Therapeutics and in 2017 became the first prescription digital therapeutic authorized by the FDA, through the De Novo pathway. Pear Therapeutics filed for Chapter 11 bankruptcy in April 2023 and its assets were sold at auction, but reSET itself is still sold and supported today: PursueCare relaunched it as RESET in October 2024, and XRHealth acquired PursueCare, including RESET and RESET-O, in November 2026.

Can Pear Therapeutics (reSET) be used with protected health information?

We have not verified a BAA statement from Pear Therapeutics (reSET)

The vendor's own published pages do not state whether it signs a Business Associate Agreement. Unverified items are shown as Unknown on this profile, never guessed. Confirm with the vendor before using this product with protected health information.

Last verified November 18, 2026

At a Glance

Deploymentcloud
Mobile Apptrue

Share:

Pricing

Contact vendor for pricing

Get a quote for Pear Therapeutics (reSET)

Ad
Favicon

 

  
 

Similar to Pear Therapeutics (reSET)

Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  

Top Rated Pear Therapeutics (reSET) Alternatives

Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  

Have you used Pear Therapeutics (reSET)?

Share your experience to help healthcare professionals make better decisions.

Explore More